APO Research
Talk to an analyst

APO RESEARCH · REPORT

Minimally Invasive Endoscopic Therapeutic Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Minimally Invasive Endoscopic Therapeutic Device Market Outlook and Growth Opportunities 2026

8 January 2026199 pages

Choose your research edition.

Industry ResearchMinimally Invasive Endoscopic Therapeutic Device Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Minimally Invasive Endoscopic Therapeutic Device Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Minimally Invasive Endoscopic Therapeutic Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Minimally Invasive Endoscopic Therapeutic Device Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Minimally Invasive Endoscopic Therapeutic Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Minimally Invasive Endoscopic Therapeutic Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Minimally Invasive Endoscopic Therapeutic Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Minimally Invasive Endoscopic Therapeutic Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Minimally Invasive Endoscopic Therapeutic Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Minimally Invasive Endoscopic Therapeutic Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Minimally Invasive Endoscopic Therapeutic Device market include Olympus, Boston Scientific, Cook Medical, Micro Tech, Medtronic, CONMED, Endo-Flex, Taewoong Medical and Always Good Solutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Minimally Invasive Endoscopic Therapeutic Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Minimally Invasive Endoscopic Therapeutic Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Minimally Invasive Endoscopic Therapeutic Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Minimally Invasive Endoscopic Therapeutic Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Minimally Invasive Endoscopic Therapeutic Device Segment by Company

Olympus

Boston Scientific

Cook Medical

Micro Tech

Medtronic

CONMED

Endo-Flex

Taewoong Medical

Always Good Solutions

KARL STORZ

HOYA

Argon Medical

Anrui Medical

Cardinal Health

B. Braun

Minimally Invasive Endoscopic Therapeutic Device Segment by Type

Biopsy

Hemostasis and Closure

Dilation

EUS

EMR/ESD

ERCP

Minimally Invasive Endoscopic Therapeutic Device Segment by Application

Gastroenterology

Respiratory

Other

Minimally Invasive Endoscopic Therapeutic Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Minimally Invasive Endoscopic Therapeutic Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Minimally Invasive Endoscopic Therapeutic Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Minimally Invasive Endoscopic Therapeutic Device significant trends, drivers, influence factors in global and regions.

6. To analyze Minimally Invasive Endoscopic Therapeutic Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Minimally Invasive Endoscopic Therapeutic Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Minimally Invasive Endoscopic Therapeutic Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Minimally Invasive Endoscopic Therapeutic Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Minimally Invasive Endoscopic Therapeutic Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Minimally Invasive Endoscopic Therapeutic Device industry.

Chapter 3: Detailed analysis of Minimally Invasive Endoscopic Therapeutic Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Minimally Invasive Endoscopic Therapeutic Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Minimally Invasive Endoscopic Therapeutic Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Minimally Invasive Endoscopic Therapeutic Device Industry Trends Table 2. Minimally Invasive Endoscopic Therapeutic Device Industry Drivers Table 3. Minimally Invasive Endoscopic Therapeutic Device Industry Opportunities and Challenges Table 4. Minimally Invasive Endoscopic Therapeutic Device Industry Restraints Table 5. Global Minimally Invasive Endoscopic Therapeutic Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Minimally Invasive Endoscopic Therapeutic Device Revenue Share by Company (2021-2026) Table 7. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Company (2021-2026) Table 9. Global Minimally Invasive Endoscopic Therapeutic Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Minimally Invasive Endoscopic Therapeutic Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Minimally Invasive Endoscopic Therapeutic Device Key Company Manufacturing Base & Headquarters Table 12. Global Minimally Invasive Endoscopic Therapeutic Device Company, Product Type & Application Table 13. Global Minimally Invasive Endoscopic Therapeutic Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Minimally Invasive Endoscopic Therapeutic Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Biopsy Table 18. Significant Companies of Hemostasis and Closure Table 19. Significant Companies of Dilation Table 20. Significant Companies of EUS Table 21. Significant Companies of EMR/ESD Table 22. Significant Companies of ERCP Table 23. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Type (2021-2026) & (k units) Table 25. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Type (2027-2032) & (k units) Table 26. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Type (2021-2026) Table 27. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Type (2027-2032) Table 28. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type (2021-2026) Table 32. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Gastroenterology Table 34. Significant Companies of Respiratory Table 35. Significant Companies of Other Table 36. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Application (2021-2026) & (k units) Table 38. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Application (2027-2032) & (k units) Table 39. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Application (2021-2026) Table 40. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Application (2027-2032) Table 41. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application (2021-2026) Table 45. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application (2027-2032) Table 46. Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region (2021-2026) & (k units) Table 48. Global Minimally Invasive Endoscopic Therapeutic Device Sales Market Share by Region (2021-2026) Table 49. Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region (2027-2032) & (k units) Table 50. Global Minimally Invasive Endoscopic Therapeutic Device Sales Market Share by Region (2027-2032) Table 51. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Region (2021-2026) Table 54. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Region (2027-2032) Table 56. Global Minimally Invasive Endoscopic Therapeutic Device Market Average Price (USD/unit) by Region (2021-2026) Table 57. Global Minimally Invasive Endoscopic Therapeutic Device Market Average Price (USD/unit) by Region (2027-2032) Table 58. Global Minimally Invasive Endoscopic Therapeutic Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Minimally Invasive Endoscopic Therapeutic Device Sales by Country (2021-2026) & (k units) Table 61. Global Minimally Invasive Endoscopic Therapeutic Device Sales Market Share by Country (2021-2026) Table 62. Global Minimally Invasive Endoscopic Therapeutic Device Sales by Country (2027-2032) & (k units) Table 63. Global Minimally Invasive Endoscopic Therapeutic Device Sales Market Share by Country (2027-2032) Table 64. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Market Share by Country (2021-2026) Table 66. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Market Share by Country (2027-2032) Table 68. Olympus Company Information Table 69. Olympus Business Overview Table 70. Olympus Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Olympus Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 72. Olympus Recent Development Table 73. Boston Scientific Company Information Table 74. Boston Scientific Business Overview Table 75. Boston Scientific Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Boston Scientific Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 77. Boston Scientific Recent Development Table 78. Cook Medical Company Information Table 79. Cook Medical Business Overview Table 80. Cook Medical Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Cook Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 82. Cook Medical Recent Development Table 83. Micro Tech Company Information Table 84. Micro Tech Business Overview Table 85. Micro Tech Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Micro Tech Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 87. Micro Tech Recent Development Table 88. Medtronic Company Information Table 89. Medtronic Business Overview Table 90. Medtronic Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Medtronic Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 92. Medtronic Recent Development Table 93. CONMED Company Information Table 94. CONMED Business Overview Table 95. CONMED Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. CONMED Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 97. CONMED Recent Development Table 98. Endo-Flex Company Information Table 99. Endo-Flex Business Overview Table 100. Endo-Flex Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Endo-Flex Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 102. Endo-Flex Recent Development Table 103. Taewoong Medical Company Information Table 104. Taewoong Medical Business Overview Table 105. Taewoong Medical Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Taewoong Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 107. Taewoong Medical Recent Development Table 108. Always Good Solutions Company Information Table 109. Always Good Solutions Business Overview Table 110. Always Good Solutions Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Always Good Solutions Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 112. Always Good Solutions Recent Development Table 113. KARL STORZ Company Information Table 114. KARL STORZ Business Overview Table 115. KARL STORZ Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. KARL STORZ Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 117. KARL STORZ Recent Development Table 118. HOYA Company Information Table 119. HOYA Business Overview Table 120. HOYA Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. HOYA Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 122. HOYA Recent Development Table 123. Argon Medical Company Information Table 124. Argon Medical Business Overview Table 125. Argon Medical Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Argon Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 127. Argon Medical Recent Development Table 128. Anrui Medical Company Information Table 129. Anrui Medical Business Overview Table 130. Anrui Medical Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Anrui Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 132. Anrui Medical Recent Development Table 133. Cardinal Health Company Information Table 134. Cardinal Health Business Overview Table 135. Cardinal Health Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Cardinal Health Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 137. Cardinal Health Recent Development Table 138. B. Braun Company Information Table 139. B. Braun Business Overview Table 140. B. Braun Minimally Invasive Endoscopic Therapeutic Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. B. Braun Minimally Invasive Endoscopic Therapeutic Device Product Portfolio Table 142. B. Braun Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Minimally Invasive Endoscopic Therapeutic Device Distributors List Table 146. Minimally Invasive Endoscopic Therapeutic Device Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Minimally Invasive Endoscopic Therapeutic Device Product Image Figure 2. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Minimally Invasive Endoscopic Therapeutic Device Sales (2021-2032) & (k units) Figure 5. Global Minimally Invasive Endoscopic Therapeutic Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Minimally Invasive Endoscopic Therapeutic Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Biopsy Image Figure 10. Hemostasis and Closure Image Figure 11. Dilation Image Figure 12. EUS Image Figure 13. EMR/ESD Image Figure 14. ERCP Image Figure 15. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Type (2021-2032) Figure 18. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type (2021-2032) Figure 21. Gastroenterology Image Figure 22. Respiratory Image Figure 23. Other Image Figure 24. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Application (2021-2032) Figure 27. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application (2021-2032) Figure 30. Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Minimally Invasive Endoscopic Therapeutic Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032) & (US$ Million) Figure 35. North America Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032) & (US$ Million) Figure 41. South America Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Minimally Invasive Endoscopic Therapeutic Device Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Minimally Invasive Endoscopic Therapeutic Device Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Biopsy
  • Hemostasis and Closure
  • Dilation
  • EUS
  • EMR/ESD
  • ERCP
Applications
  • Gastroenterology
  • Respiratory
  • Other
Companies covered
  • Olympus
  • Boston Scientific
  • Cook Medical
  • Micro Tech
  • Medtronic
  • CONMED
  • Endo-Flex
  • Taewoong Medical
  • Always Good Solutions
  • KARL STORZ
  • HOYA
  • Argon Medical
  • Anrui Medical
  • Cardinal Health
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032)
  4. 1.2.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume (2021-2032)
  5. 1.2.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Minimally Invasive Endoscopic Therapeutic Device Market Dynamics
  1. 2.1 Minimally Invasive Endoscopic Therapeutic Device Industry Trends
  2. 2.2 Minimally Invasive Endoscopic Therapeutic Device Industry Drivers
  3. 2.3 Minimally Invasive Endoscopic Therapeutic Device Industry Opportunities and Challenges
  4. 2.4 Minimally Invasive Endoscopic Therapeutic Device Industry Restraints
3 Minimally Invasive Endoscopic Therapeutic Device Market by Company
  1. 3.1 Global Minimally Invasive Endoscopic Therapeutic Device Company Revenue Ranking in 2025
  2. 3.2 Global Minimally Invasive Endoscopic Therapeutic Device Revenue by Company (2021-2026)
  3. 3.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Minimally Invasive Endoscopic Therapeutic Device Average Price by Company (2021-2026)
  5. 3.5 Global Minimally Invasive Endoscopic Therapeutic Device Company Ranking (2024-2026)
  6. 3.6 Global Minimally Invasive Endoscopic Therapeutic Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Minimally Invasive Endoscopic Therapeutic Device Company Product Type and Application
  8. 3.8 Global Minimally Invasive Endoscopic Therapeutic Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Minimally Invasive Endoscopic Therapeutic Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Minimally Invasive Endoscopic Therapeutic Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Minimally Invasive Endoscopic Therapeutic Device Market by Type
  1. 4.1 Minimally Invasive Endoscopic Therapeutic Device Type Introduction
  2. 4.1.1 Biopsy
  3. 4.1.2 Hemostasis and Closure
  4. 4.1.3 Dilation
  5. 4.1.4 EUS
  6. 4.1.5 EMR/ESD
  7. 4.1.6 ERCP
  8. 4.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Type
  9. 4.2.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Type
  13. 4.3.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Type (2021-2032)
  15. 4.3.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type (2021-2032)
5 Minimally Invasive Endoscopic Therapeutic Device Market by Application
  1. 5.1 Minimally Invasive Endoscopic Therapeutic Device Application Introduction
  2. 5.1.1 Gastroenterology
  3. 5.1.2 Respiratory
  4. 5.1.3 Other
  5. 5.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Application
  6. 5.2.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Application
  10. 5.3.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application (2021-2032)
6 Minimally Invasive Endoscopic Therapeutic Device Regional Sales and Value Analysis
  1. 6.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region (2021-2032)
  3. 6.2.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region: 2021-2026
  4. 6.2.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Region (2027-2032)
  5. 6.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Region (2027-2032)
  9. 6.5 Global Minimally Invasive Endoscopic Therapeutic Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032)
  12. 6.6.2 North America Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032)
  15. 6.7.2 Europe Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032)
  21. 6.9.2 South America Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Minimally Invasive Endoscopic Therapeutic Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Country, 2025 VS 2032
7 Minimally Invasive Endoscopic Therapeutic Device Country-level Sales and Value Analysis
  1. 7.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Country (2021-2032)
  4. 7.3.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Country (2021-2026)
  5. 7.3.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales by Country (2027-2032)
  6. 7.4 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Minimally Invasive Endoscopic Therapeutic Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Minimally Invasive Endoscopic Therapeutic Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Minimally Invasive Endoscopic Therapeutic Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Olympus
  2. 8.1.1 Olympus Company Information
  3. 8.1.2 Olympus Business Overview
  4. 8.1.3 Olympus Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Olympus Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  6. 8.1.5 Olympus Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 Cook Medical
  14. 8.3.1 Cook Medical Company Information
  15. 8.3.2 Cook Medical Business Overview
  16. 8.3.3 Cook Medical Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cook Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  18. 8.3.5 Cook Medical Recent Developments
  19. 8.4 Micro Tech
  20. 8.4.1 Micro Tech Company Information
  21. 8.4.2 Micro Tech Business Overview
  22. 8.4.3 Micro Tech Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Micro Tech Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  24. 8.4.5 Micro Tech Recent Developments
  25. 8.5 Medtronic
  26. 8.5.1 Medtronic Company Information
  27. 8.5.2 Medtronic Business Overview
  28. 8.5.3 Medtronic Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Medtronic Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  30. 8.5.5 Medtronic Recent Developments
  31. 8.6 CONMED
  32. 8.6.1 CONMED Company Information
  33. 8.6.2 CONMED Business Overview
  34. 8.6.3 CONMED Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CONMED Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  36. 8.6.5 CONMED Recent Developments
  37. 8.7 Endo-Flex
  38. 8.7.1 Endo-Flex Company Information
  39. 8.7.2 Endo-Flex Business Overview
  40. 8.7.3 Endo-Flex Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Endo-Flex Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  42. 8.7.5 Endo-Flex Recent Developments
  43. 8.8 Taewoong Medical
  44. 8.8.1 Taewoong Medical Company Information
  45. 8.8.2 Taewoong Medical Business Overview
  46. 8.8.3 Taewoong Medical Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Taewoong Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  48. 8.8.5 Taewoong Medical Recent Developments
  49. 8.9 Always Good Solutions
  50. 8.9.1 Always Good Solutions Company Information
  51. 8.9.2 Always Good Solutions Business Overview
  52. 8.9.3 Always Good Solutions Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Always Good Solutions Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  54. 8.9.5 Always Good Solutions Recent Developments
  55. 8.10 KARL STORZ
  56. 8.10.1 KARL STORZ Company Information
  57. 8.10.2 KARL STORZ Business Overview
  58. 8.10.3 KARL STORZ Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 KARL STORZ Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  60. 8.10.5 KARL STORZ Recent Developments
  61. 8.11 HOYA
  62. 8.11.1 HOYA Company Information
  63. 8.11.2 HOYA Business Overview
  64. 8.11.3 HOYA Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 HOYA Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  66. 8.11.5 HOYA Recent Developments
  67. 8.12 Argon Medical
  68. 8.12.1 Argon Medical Company Information
  69. 8.12.2 Argon Medical Business Overview
  70. 8.12.3 Argon Medical Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Argon Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  72. 8.12.5 Argon Medical Recent Developments
  73. 8.13 Anrui Medical
  74. 8.13.1 Anrui Medical Company Information
  75. 8.13.2 Anrui Medical Business Overview
  76. 8.13.3 Anrui Medical Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Anrui Medical Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  78. 8.13.5 Anrui Medical Recent Developments
  79. 8.14 Cardinal Health
  80. 8.14.1 Cardinal Health Company Information
  81. 8.14.2 Cardinal Health Business Overview
  82. 8.14.3 Cardinal Health Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Cardinal Health Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  84. 8.14.5 Cardinal Health Recent Developments
  85. 8.15 B. Braun
  86. 8.15.1 B. Braun Company Information
  87. 8.15.2 B. Braun Business Overview
  88. 8.15.3 B. Braun Minimally Invasive Endoscopic Therapeutic Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 B. Braun Minimally Invasive Endoscopic Therapeutic Device Product Portfolio
  90. 8.15.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Minimally Invasive Endoscopic Therapeutic Device Value Chain Analysis
  2. 9.1.1 Minimally Invasive Endoscopic Therapeutic Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Minimally Invasive Endoscopic Therapeutic Device Sales Mode & Process
  6. 9.2 Minimally Invasive Endoscopic Therapeutic Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Minimally Invasive Endoscopic Therapeutic Device Distributors
  9. 9.2.3 Minimally Invasive Endoscopic Therapeutic Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst